Adage Capital Partners
ANRO icon

Adage Capital Partners’s Alto Neuroscience ANRO Stock Holding History

Adage Capital Partners’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.65M Buy
+385,000
New +$7.14M 0.01% 717

Other funds holding ANRO

AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SSC
Spruce Street Capital New York $416M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Adage Capital Partners's ANRO Position: Q1 2026 in Review

Adage Capital Partners opened a new position in Alto Neuroscience (ANRO) in Q1 2026: 385,000 shares worth $8.65M. The stake represents 0.01% of the portfolio and ranks #717 among its holdings.

110 funds tracked by Wall St. Rank hold ANRO as of Q1 2026.

  • Adage Capital Partners held 385,000 shares of Alto Neuroscience worth $8.65M as of Q1 2026.
  • Alto Neuroscience was a new Adage Capital Partners position in Q1 2026.
  • Alto Neuroscience made up 0.01% of Adage Capital Partners's portfolio in Q1 2026, its #717 holding.
  • 110 funds tracked by Wall St. Rank held Alto Neuroscience as of Q1 2026.

Based on Adage Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.